ES2603381T3 - Derivados de prostaglandinas para tratar el estreñimiento - Google Patents

Derivados de prostaglandinas para tratar el estreñimiento Download PDF

Info

Publication number
ES2603381T3
ES2603381T3 ES05782157.1T ES05782157T ES2603381T3 ES 2603381 T3 ES2603381 T3 ES 2603381T3 ES 05782157 T ES05782157 T ES 05782157T ES 2603381 T3 ES2603381 T3 ES 2603381T3
Authority
ES
Spain
Prior art keywords
composition
constipation
compound
administered
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05782157.1T
Other languages
English (en)
Spanish (es)
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Sucampo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35229739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2603381(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sucampo GmbH filed Critical Sucampo GmbH
Application granted granted Critical
Publication of ES2603381T3 publication Critical patent/ES2603381T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES05782157.1T 2004-09-02 2005-09-01 Derivados de prostaglandinas para tratar el estreñimiento Expired - Lifetime ES2603381T3 (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US60652104P 2004-09-02 2004-09-02
US606521P 2004-09-02
US66631705P 2005-03-30 2005-03-30
US666317P 2005-03-30
US66659305P 2005-03-31 2005-03-31
US666593P 2005-03-31
PCT/JP2005/016464 WO2006025599A1 (en) 2004-09-02 2005-09-01 Prostaglandin derivatives for treating gastrointestinal disorder

Publications (1)

Publication Number Publication Date
ES2603381T3 true ES2603381T3 (es) 2017-02-27

Family

ID=35229739

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05782157.1T Expired - Lifetime ES2603381T3 (es) 2004-09-02 2005-09-01 Derivados de prostaglandinas para tratar el estreñimiento

Country Status (16)

Country Link
US (2) US8748481B2 (enExample)
EP (1) EP1791545B1 (enExample)
JP (4) JP2008511541A (enExample)
KR (4) KR20180033310A (enExample)
CN (1) CN102885821A (enExample)
AR (1) AR050626A1 (enExample)
AU (1) AU2005278323B2 (enExample)
BR (1) BRPI0514891A (enExample)
CA (1) CA2577284A1 (enExample)
ES (1) ES2603381T3 (enExample)
IL (1) IL181332A (enExample)
MX (1) MX2007002602A (enExample)
NO (1) NO340989B1 (enExample)
NZ (1) NZ553434A (enExample)
TW (1) TWI387454B (enExample)
WO (1) WO2006025599A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE539756T1 (de) * 2002-10-23 2012-01-15 Sucampo Ag Prostaglandinsubstanzen für die behandlung von fettsucht
DE602004030245D1 (de) * 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
EP2682130A1 (en) 2006-01-24 2014-01-08 R-Tech Ueno, Ltd. Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
US20090030072A1 (en) * 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound
CN108685929A (zh) * 2012-04-23 2018-10-23 苏坎波公司 用于治疗具有腹泻的肠易激综合征的方法
CA2899834C (en) 2013-02-04 2020-09-01 Taisho Pharmaceutical Co., Ltd. Use of 4-isopropylphenyl glucitol compounds in the treatment of constipation
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380709A (en) 1987-01-28 1995-01-10 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5317032A (en) 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
DK1426361T4 (en) 1999-10-15 2015-03-16 Sucampo Ag Novel compounds containing a bi-cyclic compound and a glyceride
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
CA2445651C (en) 2001-05-18 2011-08-09 Sucampo Ag Cathartic composition comprising halogenated prostaglandin derivatives
BR0212233A (pt) 2001-08-31 2004-10-05 Sucampo Ag Abridor de canal de cloreto
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
TWI263505B (en) 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener
AU2003292556B2 (en) 2002-12-27 2009-09-10 Sucampo Ag Derivatives of prostaglandins for treating abdominal discomfort
DE602004030245D1 (de) 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner

Also Published As

Publication number Publication date
KR20180033310A (ko) 2018-04-02
CN102885821A (zh) 2013-01-23
AR050626A1 (es) 2006-11-08
TW200612901A (en) 2006-05-01
JP2018150354A (ja) 2018-09-27
JP2008511541A (ja) 2008-04-17
IL181332A0 (en) 2007-07-04
KR20140019006A (ko) 2014-02-13
BRPI0514891A (pt) 2008-06-24
US20140315994A1 (en) 2014-10-23
TWI387454B (zh) 2013-03-01
IL181332A (en) 2015-09-24
EP1791545B1 (en) 2016-08-31
JP2015166377A (ja) 2015-09-24
MX2007002602A (es) 2007-04-25
NO340989B1 (no) 2017-07-31
EP1791545A1 (en) 2007-06-06
NZ553434A (en) 2010-01-29
KR20070048221A (ko) 2007-05-08
US20060063830A1 (en) 2006-03-23
WO2006025599A1 (en) 2006-03-09
CA2577284A1 (en) 2006-03-09
AU2005278323A1 (en) 2006-03-09
KR20170003712A (ko) 2017-01-09
JP2013049688A (ja) 2013-03-14
AU2005278323B2 (en) 2011-03-17
JP6408426B2 (ja) 2018-10-17
NO20071704L (no) 2007-05-31
US8748481B2 (en) 2014-06-10

Similar Documents

Publication Publication Date Title
JP6408426B2 (ja) 胃腸障害処置用プロスタグランジン誘導体
US20130143958A1 (en) Dosage unit comprising a prostaglandin analog for treating constipation
BRPI0114042B1 (pt) uso de composto bicíclico na fabricação de uma composição para alívio ou prevenção de constipação em um paciente humano constipado e limpeza de intestinos
ES2282408T3 (es) 15-ceto-prostaglandina para el tratamiento de estreñimiento por farmaco.
JP2010532314A (ja) Ｎｓａｉｄおよびプロスタグランジン化合物の医薬的組み合わせ
US10561649B2 (en) Pharmaceutical combination of opioid and prostaglandin compound
RU2392941C2 (ru) Производные простагландинов для лечения желудочно-кишечного нарушения
US20130281526A1 (en) Method for treating irritable bowel syndrome with diarrhea